Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion type Assertion NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_head.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion description "[Our results may explain the ineffectiveness of some SSTR2 selective SRIH analogues in the treatment of prostate cancer and suggest that the absence of SSTR2 could represent a growth advantage in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_provenance.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion evidence source_evidence_literature NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_provenance.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion SIO_000772 9253335 NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_provenance.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion wasDerivedFrom befree-20150227 NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_provenance.
- NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_assertion wasGeneratedBy ECO_0000203 NP714407.RATsnU_Mjtw3fZ3NPRmCsBVj9A32z9oxj_buUA8vrznjM130_provenance.